Mizuho Lays Out Framework for BridgeBio Pharma (BBIO) Trading Today Following Results: 'we wouldn't be terribly surprised if the stock trades north of ~$20'
Tweet Send to a Friend
Mizuho Securities analyst Salim Syed reiterated a Buy rating and $23.00 price target on BridgeBio Pharma (NASDAQ: BBIO).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
